{"_buckets": {"deposit": "87bc399c-9aa9-498f-ae36-cbf63bfba466"}, "_deposit": {"id": "3819", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "3819"}, "status": "published"}, "_oai": {"id": "oai:soar-ir.repo.nii.ac.jp:00003819", "sets": ["461:462"]}, "item_6_biblio_info_6": {"attribute_name": "\u66f8\u8a8c\u60c5\u5831", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2009-07", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "7", "bibliographicPageEnd": "417", "bibliographicPageStart": "413", "bibliographicVolumeNumber": "39", "bibliographic_titles": [{"bibliographic_title": "JAPANESE JOURNAL OF CLINICAL ONCOLOGY"}]}]}, "item_6_description_20": {"attribute_name": "\u6284\u9332", "attribute_value_mlt": [{"subitem_description": "The aim of this study was to investigate the risk factors for dysphagia induced by chemoradiotherapy for head and neck cancers. Forty-seven patients with head and neck cancers who underwent definitive chemoradiotherapy from December 1998 to March 2006 were reviewed retrospectively. Median age was 63 years (range, 16-81). The locations of the primary lesion were as follows: larynx in 18 patients, oropharynx in 11, nasopharynx in 7, hypopharynx in 7 and others in 4. Clinical stages were as follows: Stage II in 20 and Stages III-IV in 27. Almost all patients underwent platinum-based concomitant chemoradiotherapy. The median cumulative dose of cisplatin was 100 mg/m(2) (range, 80-300) and median radiation dose was 70 Gy (range, 50-70). Severe dysphagia (Grade 3-4) was observed in 22 patients (47%) as an acute toxic event. One patient required tube feeding even at 12-month follow-up. In univariate analysis, clinical stage (III-IV) (P = 0.017), primary site (oro-hypopharynx) (P = 0.041) and radiation portal size (\u003e 11 cm) (P \u003c 0.001) were found to be associated with severe dysphagia. In multivariate analysis, only radiation portal size was found to have a significant relationship with severe dysphagia (P = 0.048). Larger radiation portal field was associated with severe dysphagia induced by chemoradiotherapy.", "subitem_description_type": "Abstract"}]}, "item_6_description_30": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7\uff08\u30b3\u30f3\u30c6\u30f3\u30c4\u306e\u7a2e\u985e\uff09", "attribute_value_mlt": [{"subitem_description": "Article", "subitem_description_type": "Other"}]}, "item_6_description_5": {"attribute_name": "\u5f15\u7528", "attribute_value_mlt": [{"subitem_description": "JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 39(7):413-417 (2009)", "subitem_description_type": "Other"}]}, "item_6_link_3": {"attribute_name": "\u4fe1\u5dde\u5927\u5b66\u7814\u7a76\u8005\u7dcf\u89a7\u3078\u306e\u30ea\u30f3\u30af", "attribute_value_mlt": [{"subitem_link_text": "Koiwai, Keiichiro", "subitem_link_url": "http://soar-rd.shinshu-u.ac.jp/profile/ja.gCkCgUkh.html"}]}, "item_6_link_67": {"attribute_name": "WoS", "attribute_value_mlt": [{"subitem_link_text": "Web of Science", "subitem_link_url": "http://gateway.isiknowledge.com/gateway/Gateway.cgi?\u0026GWVersion=2\u0026SrcAuth=ShinshuUniv\u0026SrcApp=ShinshuUniv\u0026DestLinkType=FullRecord\u0026DestApp=WOS\u0026KeyUT=000267441600001"}]}, "item_6_publisher_4": {"attribute_name": "\u51fa\u7248\u8005", "attribute_value_mlt": [{"subitem_publisher": "OXFORD UNIV PRESS"}]}, "item_6_relation_47": {"attribute_name": "PubMed", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "19383615"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search\u0026DB=pubmed\u0026term=19383615", "subitem_relation_type_select": "PMID"}}]}, "item_6_relation_48": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "10.1093/jjco/hyp033"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "http://dx.doi.org/10.1093/jjco/hyp033", "subitem_relation_type_select": "DOI"}}]}, "item_6_rights_62": {"attribute_name": "\u6a29\u5229", "attribute_value_mlt": [{"subitem_rights": "Copyright\u00a9 The Author 2009. Published by Oxford University Press."}, {"subitem_rights": "This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Jpn. J. Clin. Oncol. following peer review. The definitive publisher-authenticated version Jpn. J. Clin. Oncol. (2009) 39 (7): 413-417 is available online at: doi: 10.1093/jjco/hyp033"}]}, "item_6_select_64": {"attribute_name": "\u8457\u8005\u7248\u30d5\u30e9\u30b0", "attribute_value_mlt": [{"subitem_select_item": "author"}]}, "item_6_source_id_35": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0368-2811", "subitem_source_identifier_type": "ISSN"}]}, "item_6_source_id_39": {"attribute_name": "NII ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0368-2811", "subitem_source_identifier_type": "ISSN"}]}, "item_6_source_id_40": {"attribute_name": "\u66f8\u8a8c\u30ec\u30b3\u30fc\u30c9ID", "attribute_value_mlt": [{"subitem_source_identifier": "AA00690866", "subitem_source_identifier_type": "NCID"}]}, "item_6_text_69": {"attribute_name": "wosonly authkey", "attribute_value_mlt": [{"subitem_text_value": "toxicity; combined modality therapy; head and neck neoplasm; dysphagia; radiotherapy"}]}, "item_6_text_70": {"attribute_name": "wosonly keywords", "attribute_value_mlt": [{"subitem_text_value": "LOCALLY ADVANCED HEAD; INTENSITY-MODULATED RADIOTHERAPY; SQUAMOUS-CELL CARCINOMA; RADIATION-THERAPY; CHEMORADIATION; PREVENTION; ASPIRATION"}]}, "item_6_textarea_68": {"attribute_name": "wosonly abstract", "attribute_value_mlt": [{"subitem_textarea_value": "The aim of this study was to investigate the risk factors for dysphagia induced by chemoradiotherapy for head and neck cancers. Forty-seven patients with head and neck cancers who underwent definitive chemoradiotherapy from December 1998 to March 2006 were reviewed retrospectively. Median age was 63 years (range, 16-81). The locations of the primary lesion were as follows: larynx in 18 patients, oropharynx in 11, nasopharynx in 7, hypopharynx in 7 and others in 4. Clinical stages were as follows: Stage II in 20 and Stages III-IV in 27. Almost all patients underwent platinum-based concomitant chemoradiotherapy. The median cumulative dose of cisplatin was 100 mg/m(2) (range, 80-300) and median radiation dose was 70 Gy (range, 50-70). Severe dysphagia (Grade 3-4) was observed in 22 patients (47%) as an acute toxic event. One patient required tube feeding even at 12-month follow-up. In univariate analysis, clinical stage (III-IV) (P = 0.017), primary site (oro-hypopharynx) (P = 0.041) and radiation portal size (\u003e 11 cm) (P \u003c 0.001) were found to be associated with severe dysphagia. In multivariate analysis, only radiation portal size was found to have a significant relationship with severe dysphagia (P = 0.048). Larger radiation portal field was associated with severe dysphagia induced by chemoradiotherapy."}]}, "item_creator": {"attribute_name": "\u8457\u8005", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Koiwai,  Keiichiro"}], "nameIdentifiers": [{"nameIdentifier": "7253", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shikama,  Naoto"}], "nameIdentifiers": [{"nameIdentifier": "7254", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sasaki,  Shigeru"}], "nameIdentifiers": [{"nameIdentifier": "7255", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shinoda,  Atsunori"}], "nameIdentifiers": [{"nameIdentifier": "7256", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kadoya,  Masumi"}], "nameIdentifiers": [{"nameIdentifier": "7257", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "\u30d5\u30a1\u30a4\u30eb\u60c5\u5831", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2015-09-24"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "Risk_factors_severe_dysphagia_after_concurrent_chemoradiotherapy.pdf", "filesize": [{"value": "168.8 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 168800.0, "url": {"label": "Risk_factors_severe_dysphagia_after_concurrent_chemoradiotherapy.pdf", "url": "https://soar-ir.repo.nii.ac.jp/record/3819/files/Risk_factors_severe_dysphagia_after_concurrent_chemoradiotherapy.pdf"}, "version_id": "09835a43-1e3f-45ec-924a-8e3d4a151d9b"}]}, "item_keyword": {"attribute_name": "\u30ad\u30fc\u30ef\u30fc\u30c9", "attribute_value_mlt": [{"subitem_subject": "toxicity", "subitem_subject_scheme": "Other"}, {"subitem_subject": "combined modality therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "head and neck neoplasm", "subitem_subject_scheme": "Other"}, {"subitem_subject": "dysphagia", "subitem_subject_scheme": "Other"}, {"subitem_subject": "radiotherapy", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "\u8a00\u8a9e", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Risk Factors for Severe Dysphagia after Concurrent Chemoradiotherapy for Head and Neck Cancers", "item_titles": {"attribute_name": "\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_title": "Risk Factors for Severe Dysphagia after Concurrent Chemoradiotherapy for Head and Neck Cancers"}]}, "item_type_id": "6", "owner": "1", "path": ["461/462"], "permalink_uri": "http://hdl.handle.net/10091/16251", "pubdate": {"attribute_name": "\u516c\u958b\u65e5", "attribute_value": "2013-02-13"}, "publish_date": "2013-02-13", "publish_status": "0", "recid": "3819", "relation": {}, "relation_version_is_last": true, "title": ["Risk Factors for Severe Dysphagia after Concurrent Chemoradiotherapy for Head and Neck Cancers"], "weko_shared_id": 3}